The drug target and model provide a comprehensive perspective to study the prognostic features and treatment of HF, and the newly discovered TAP1-mediated miRNA-regulated diagnostic model may provide new insights into the current knowledge of the mechanisms of HF initiation and progression as well as a new idea and basis for further study of HF treatment options. The gene discussed is TAP1; the disease is hydrops fetalis.